Besides, CDCA5 was found to be transcribed by E2F1, and could promote oncogenesis by enhancing cell proliferation and inhibiting apoptosis via the AKT pathway in HCC [28]. The gene discussed is E2F1; the disease is hepatocellular carcinoma.